About the Presenters
Module 1 – Introduction to Biomonitoring (COMPLETED)
Nancy B. Hopf, PhD is currently a senior researcher performing occupational exposure assessments at the Institute for Work and Health (IST), Switzerland. Previous responsibilities include evaluating toxicology, exposure, and epidemiological evidence for classification of carcinogens for the International Agency for Research on Cancer (IARC), performing retrospective and current exposure assessments at the National Institute for Occupational Safety and Health (NIOSH), and performing risk assessments as a regulatory official for the Norwegian Directorate for Labour Inspection. Dr. Hopf received her PhD in Occupational and Environmental Health, specializing in biological monitoring, from the University of Cincinnati (UC), USA, and her MSc in organic chemistry from the University of Oslo, Norway. Dr. Hopf is a current member of the ACGIH® Biological Exposure Indices (BEI®) Committee.
Also contributing to the development of this module:
Leena A. Nylander-French, PhD, CIH has dedicated her scholarship to explore the interface between exposure science, toxicology, genomics, and human health effects. She focuses on understanding the consequences of human exposure to toxic substances in order to establish the relationship between exposure and mechanisms of toxicity leading to disease. Her research group has pioneered approaches to quantitatively measure both skin and inhalation exposures to toxicants and the related biomarkers. Her research projects are full-scale occupational and environmental studies incorporating both methods development in the laboratory as well as health surveys where individual exposures are monitored using a battery of exposure measurement techniques (inhalation, skin, and biological monitoring) multiple times over an extended period. Currently, she is developing exposure assessment methodologies to investigate the role of individual genetic and epigenetic alterations to variations observed in biomarker levels after exposure to xenobiotics and to understand the impact and plausibility of these alterations on development of disease in exposed populations. Dr. Nylander-French is a current member of the ACGIH® Biological Exposure Indices (BEI®) Committee.
Glenn Talaska, PhD, CIH is the author of over 130 peer-reviewed publications in the field. Dr. Talaska currently serves as the Vice-Chair of the ACGIH® Biological Exposure Indices (BEI®) Committee and as a member of the editorial boards of several journals related to biomonitoring. Dr. Talaska’s research program develops, validates and implements non-invasive biomonitoring for workplace and carcinogen exposure.
Larry K. Lowry, PhD currently teaches in a Master’s program in environmental science at the University of Texas Health Science Center at Tyler. Dr. Lowry received his PhD in Comparative Biochemistry from the University of California at Davis and spent 20 years at NIOSH conducting exposure assessment studies using biological monitoring. Dr. Lowry is a charter member and current Chair of the ACGIH® Biological Exposure Indices (BEI®) Committee.
Also contributing to the development of this module:
John Cocker, PhD is a Fellow at the UK Health & Safety Laboratory with over 40 years of experience in biological monitoring and over 100 peer-reviewed publications. He is a member of the ACGIH® Biological Exposure Indices (BEI®) Committee, a member of the European Scientific Committee on Occupational Exposure Limits and an occasional advisor to the World Health Organization. He is an assistant editor for the Annals of Occupational Hygiene and a passionate advocate of biological monitoring.
Heiko U. Käfferlein, PhD heads the Center of Toxicology of the Institute for Prevention and Occupational Medicine of the Ruhr University Bochum, Germany and the German Social Accident Insurance. He is also head of the Division of Molecular Tumor Biology of the Protein Research Unit Ruhr within Europe. He carries out molecular-epidemiological research and training programs in community and clinical settings to advance science in cancer prevention with particular focus on biomarkers of exposure and health effects of carcinogenic, mutagenic and reproductive toxicants. His interests are predominantly in work-related cancers such as those of the bladder, lung and skin. As part of his job he is responsible for exposure and risk assessment including risk management and risk communication on chemically-induced diseases at the workplace for the German Social Accident Insurance. Dr. Käfferlein is also a member of the ACGIH® Biological Exposure Indices (BEI®) Committee.
Module 3 – Practical Considerations of Biomonitoring
Gary Spies, MPH, CIH is currently the Director of Environment, Health and Safety at Pfizer in Kalamazoo, Michigan. He has over 30 years of EHS experience in the biotechnology, chemical and pharmaceutical industries. He has been a member of the ACGIH® Biological Exposure Indices (BEI®) Committee for over 20 years. Mr. Spies has been an instructor of numerous Professional Development Courses and guest lecturer at the University of Missouri, St. Louis, University of Michigan, and Western Michigan University. He was named a Fellow of the American Industrial Hygiene Association in 2009.
Michael Bader, PD studied chemistry at the University of Muenster (Germany) and received his doctoral degree in 1996 from the University of Erlangen-Nuremberg (Germany) for his dissertation on quantitative GC-MS analyses of protein adducts of alkylating chemicals. He specialized in human biomonitoring and analytical toxicology, and received the venia legendi in occupational and environmental toxicology in 2007 at Hannover Medical School (Germany). Since 2010, he has been responsible for the human biomonitoring group of the Occupational Medicine & Health Protection Department at BASF SE, Ludwigshafen/Germany. Dr. Bader is a member of the Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) of the German Research Foundation (DFG) and its working groups Analyses in Biological Materials and Setting of Limit Values in Biological Materials. He is chairman of the ad-hoc working group Dermal Absorption of the MAK Commission, and a member of the ACGIH® Biological Exposure Indices (BEI®) Committee.
Lee M. Blum, PhD is currently an Assistant Laboratory Director and Toxicologist with NMS Labs in Willow Grove, PA. Dr. Blum earned a PhD from Thomas Jefferson University and works in the field of bioanalytical toxicology testing bodily fluids and tissues for drugs and chemicals in support of the forensic, clinical, and occupational and environmental communities. He is also an adjunct faculty member in the School of Population Health and the College of Biomedical Sciences at Thomas Jefferson University in Philadelphia, PA. He is a Fellow of the American Board of Forensic Toxicology and the American Industrial Hygiene Association (AIHA). In addition to being a member of the ACGIH® Biological Exposure Indices (BEI®) Committee, he is a member and former chair of the AIHA Biological Monitoring Committee.
Also contributing to the development of the Certificate Program:
Jean Grassman, MS, PhD, CPH is an Associate Professor at the City University of New York School of Public Health and Health Policy. Her research interests include occupational and environmental health, biological monitoring in industrial hygiene, epidemiology and risk assessment, ethical use of genetic testing, and environmental justice. Her current research examines the impact of persistent organic pollutants and plasticizers upon cellular signaling and protein function using easily accessible sources such as blood, urine, and skin cells. She has published articles on topics related to susceptibility to illness after exposure to environmental toxicants such as Agent Orange. She is a member of the ACGIH® Biological Exposure Indices (BEI®) Committee. She received her PhD and MS in Environmental Health Sciences from the University of California-Berkeley. She teaches urban environmental health, physiology, pathophysiology, and occupational health/industrial hygiene.